Menu

Research, development and production

For many years, Lusofarmaco has been mainly a national company, with a portfolio focused on well-established medicinal products, which have been the reference drugs in their respective therapeutic areas.
 
Since 1983, with the entry into the Menarini Group, Lusofarmaco has had the opportunity to take a new leap into the future in the continuity of its tradition.
 
By joining a large international pharmaceutical group, Lusofarmaco has progressively increased its product pipeline with innovative drugs in a pharmaceutical market characterized by growing competitiveness and greater need for investment.
 
MENARINI Research and Development

MENARINI Production

 

Controls Controls Research Manufacturing

Our products

Lusofarmaco can claim extensive know-how in various therapeutic areas: cardiovascular and respiratory diseases, antibiotic therapy, neuropsychiatry and gynecology.

Research & Development

For many years, Lusofarmaco has been mainly a national company, with a portfolio focused on well-established medicinal products, which have been the reference drugs in their respective therapeutic areas.

Pharmacovigilance

Pharmacovigilance: what does it mean to monitor drugs?

Registered Office:
Milanofiori – Strada 6, Edificio L – 20089 Rozzano (MI)
Tel. 02-516555.1

Registration No. In Registrar Of Companies: 00714810157
Registrar Of Companies' Office: Milano
Registered Capital: € 130.000 I.V.
Capital Reported In Last Financial Statement: € 130.000
Company subject to the direction and coordination of A. Menarini Industrie Farmaceutiche Riunite Srl

SITEMAP

Copyright 2024 Istituto Lusofarmaco D'Italia S.p.A.